We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-13.33%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$98.7B
AUM Growth
-$13.4B
Cap. Flow
+$3.55B
Cap. Flow %
3.6%
Top 10 Hldgs %
17.21%
Holding
8,079
New
273
Increased
3,486
Reduced
3,341
Closed
357

Sector Composition

Rank Sector Weight
1 Technology 5.78%
2 Financials 5.08%
3 Healthcare 4.24%
4 Consumer Discretionary 4.16%
5 Energy 3.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BC icon
6926
CALL
Brunswick
BC
$5.34B
$14K ﹤0.01%
300
-900
-75% -$48.1K
CHGG icon
6927
CALL
Chegg
CHGG
$121M
$14K ﹤0.01%
+500
New +$13.5K
CHRS icon
6928
CALL
Coherus Oncology
CHRS
$224M
$14K ﹤0.01%
1,600
CRVS icon
6929
Corvus Pharmaceuticals
CRVS
$1.1B
$14K ﹤0.01%
3,649
+640
+21% +$4.36K
DWSN icon
6930
Dawson Geophysical
DWSN
$133M
$14K ﹤0.01%
4,296
-129
-3% -$613
FRI icon
6931
First Trust S&P REIT Index Fund
FRI
$195M
$14K ﹤0.01%
650
GSAT icon
6932
Globalstar
GSAT
$10.2B
$14K ﹤0.01%
1,400
-3,056
-69% -$18.3K
HEQ
6933
John Hancock Hedged Equity & Income Fund
HEQ
$140M
$14K ﹤0.01%
1,050
-650
-38% -$9.26K
MRSN
6934
DELISTED
Mersana Therapeutics
MRSN
$14K ﹤0.01%
132
+19
+17% +$3.01K
NCSM icon
6935
NCS Multistage Holdings
NCSM
$118M
$14K ﹤0.01%
133
-2
-1% -$384
PHT
6936
DELISTED
Pioneer High Income Fund
PHT
$14K ﹤0.01%
1,700
-3,125
-65% -$26.8K
PLSE icon
6937
Pulse Biosciences
PLSE
$2.44B
$14K ﹤0.01%
1,198
+1,188
+11,880% +$14.4K
RIGL icon
6938
CALL
Rigel Pharmaceuticals
RIGL
$701M
$14K ﹤0.01%
630
+290
+85% +$8.18K
RMNI icon
6939
Rimini Street
RMNI
$459M
$14K ﹤0.01%
2,719
+35
+1% +$203
SND icon
6940
Smart Sand
SND
$181M
$14K ﹤0.01%
5,980
-122
-2% -$384
SPRO icon
6941
Spero Therapeutics
SPRO
$70.1M
$14K ﹤0.01%
2,260
-73
-3% -$591
HIE
6942
DELISTED
Miller/Howard High Income Equity Fund
HIE
$14K ﹤0.01%
1,500
MTEM
6943
DELISTED
Molecular Templates, Inc.
MTEM
$14K ﹤0.01%
218
+53
+32% +$3.7K
NSL
6944
DELISTED
NUVEEN SENIOR INCM FD
NSL
$14K ﹤0.01%
2,467
-2,595
-51% -$15.3K
NNA
6945
DELISTED
Navios Maritime Acquisition Corporation
NNA
$14K ﹤0.01%
4,166
-1
-0% -$6
SRE.PRB
6946
DELISTED
Sempra 6.75% Mandatory Convertible Preferred Stock, Series B
SRE.PRB
$14K ﹤0.01%
150
-20,324
-99% -$2.06M
CRHM
6947
DELISTED
CRH Medical Corporation
CRHM
$14K ﹤0.01%
4,700
+2,800
+147% +$9.23K
LOXO
6948
CALL
DELISTED
Loxo Oncology, Inc
LOXO
$14K ﹤0.01%
+100
New +$15.2K
HUNTW
6949
CALL
DELISTED
Hunter Maritime Acquisition Corp. Warrant
HUNTW
$14K ﹤0.01%
108,100
-64,423
-37% -$9.49K
ARKG icon
6950
ARK Genomic Revolution ETF
ARKG
$1.53B
$13K ﹤0.01%
546
+135
+33% +$3.8K

Similar funds

Citigroup's Q4 2018 Portfolio in Review

As of Q4 2018, Citigroup held 8,079 positions worth $98.7B, down 12% from $112B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Citigroup deployed $3.55B of net new capital in Q4 2018, opening 273 new positions and adding to 3,486 existing holdings. Its largest new stake was Takeda Pharmaceutical: 6,548,306 shares worth $113M.

By sector, the portfolio is most concentrated in Technology at 5.8% of assets, up from 5.1% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $1.83B trimmed.

  • Citigroup's largest Q4 2018 buy was Takeda Pharmaceutical: 6,548,306 shares worth $113M.
  • Citigroup added most to Energy Transfer Partners in Q4 2018, an estimated $560M increase.
  • Citigroup's biggest Q4 2018 reduction was iShares Russell 2000 ETF, cutting an estimated $1.83B.
  • Citigroup fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $677M.
  • Citigroup's ten largest holdings make up 17% of its $98.7B portfolio in Q4 2018.
  • Citigroup opened 273 new positions and closed 357 in Q4 2018.
  • Citigroup's portfolio value fell 12% quarter-over-quarter to $98.7B.

Based on Citigroup's 13F filing for Q4 2018, filed 12 Feb 2019.